| Discussion and file folder for RNAi stuff.  I know of only one company that is a public, pure play, and will attach an unmanaged portfolio.  That company is RNAI, the revamped RZYM.  Another player is QGENF, but it is hardly pure.  Private companies include suppliers Imgenex, Ambion, Novagen, and Dharmacon, as well as therapeutic competitor to RNAI, Anlynam. 
 Here are some important general articles relating to siRNA and delivery issues.  All are free and full text!
 
 RNA interference is mediated by 21- and 22-nucleotide RNAs
 genesdev.org
 
 Small Interfering RNAs: A Revolutionary Tool for the Analysis of Gene Function and Gene Therapy
 molinterv.aspetjournals.org
 
 RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells
 pnas.org
 
 Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells
 genesdev.org
 
 A DNA vector-based RNAi technology to suppress gene expression in mammalian cells
 pnas.org
 
 Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems
 pnas.org
 
 Retroviral delivery of small interfering RNA into primary cells
 pnas.org
 
 Links to company specific threads (pure plays only):
 
 Sirna: Subject 10854
 
 Alnylam (now publlic):  Subject 54862
 |